First Wave BioPharma (FWBI) News Today → Gold Mania (From Stansberry Research) (Ad) Free FWBI Stock Alerts $2.60 -0.19 (-6.81%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFirst Wave BioPharma (NASDAQ:FWBI) & Petros Pharmaceuticals (NASDAQ:PTPI) Head-To-Head Contrastamericanbankingnews.com - April 26 at 2:32 AMFirst Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrientsglobenewswire.com - April 24 at 7:00 AMFirst Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcasefinance.yahoo.com - April 17 at 12:00 PMFirst Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conferenceglobenewswire.com - April 15 at 7:00 AMFirst wave BioPharma CEO sells shares to cover tax obligationsinvesting.com - April 5 at 9:01 AMFirst wave BioPharma CFO sells shares worth over $5,500investing.com - March 21 at 6:57 PMFirst wave BioPharma CEO sells shares worth over $9,000investing.com - March 21 at 6:57 PMFirst Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conferenceglobenewswire.com - March 18 at 7:00 AMWhy Is First Wave BioPharma (FWBI) Stock Up Today?investorplace.com - March 14 at 8:05 AMFirst Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Diseasemsn.com - March 14 at 7:44 AMFirst Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipelineglobenewswire.com - March 14 at 6:00 AMFirst Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conferencefinance.yahoo.com - March 5 at 7:40 AMFirst Wave BioPharma to Participate In ‘Fireside Chat' at the 36th Annual Roth Conferenceglobenewswire.com - March 5 at 7:00 AMFirst Wave BioPharma Shares Drop 25% After Direct Offering Pricesmarketwatch.com - March 4 at 10:54 AMFirst Wave Biopharma to raise about $4M of proceeds in direct offeringmsn.com - March 4 at 10:54 AMFirst Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offeringfinance.yahoo.com - March 4 at 10:54 AMFirst Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024finance.yahoo.com - February 13 at 9:47 AMFirst Wave BioPharma to Present at the DealFlow MicroCap Conferencefinance.yahoo.com - January 23 at 9:40 AMThis BioPharma Could Be First To Market With Its Celiac Therapy – Phase 3 Clinical Trials To Commence In 2024benzinga.com - January 22 at 2:56 PMFirst Wave BioPharma files to sell 1.76M for holdersmsn.com - January 8 at 6:47 PMFirst Wave expecting "significant" investments if ImmunogenX deal closesmsn.com - January 6 at 9:46 AMFirst Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024finance.yahoo.com - January 4 at 9:11 AMWhat's Going On With First Wave BioPharma Stock?msn.com - January 3 at 7:27 PMmarketbeat.com - January 3 at 9:36 AMFirst Wave BioPharma price target set at $40 at Roth MKMrealmoney.thestreet.com - January 3 at 9:27 AMBuy Rating Affirmed for First Wave BioPharma Amid Strategic Focus on Celiac Treatmentmarkets.businessinsider.com - January 3 at 9:27 AMmarketbeat.com - December 28 at 12:36 PMmarketbeat.com - December 28 at 12:27 PMCrude Oil Falls Over 1%; First Wave BioPharma Shares Spike Highermarkets.businessinsider.com - December 27 at 6:31 PMWhy First Wave BioPharma Shares Are Skyrocketing Todaymsn.com - December 27 at 1:30 PMFirst Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Pricedfinance.yahoo.com - December 27 at 1:30 PMmarketbeat.com - December 27 at 12:03 PMmarketbeat.com - December 27 at 11:57 AMmarketbeat.com - December 27 at 10:01 AMmarketbeat.com - December 27 at 9:52 AMmarketbeat.com - December 27 at 9:33 AMFirst Wave BioPharma To Sell Niclosamide Program To Undisclosed Biopharmaceutical Companymarkets.businessinsider.com - December 27 at 8:30 AMFirst Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Programfinance.yahoo.com - December 27 at 8:30 AMmarketbeat.com - December 20 at 2:18 PMFWBI Stock Earnings: First Wave BioPharma Beats EPS for Q3 2023investorplace.com - December 20 at 11:05 AMFWBI Stock Earnings: First Wave BioPharma Reported Results for Q1 2023investorplace.com - December 20 at 11:05 AMUPDATED: First Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused Pipelinefinance.yahoo.com - December 18 at 6:46 PMFirst Wave BioPharma To Acquire ImmunogenX In All-stock Transactionmarkets.businessinsider.com - December 18 at 8:45 AMFirst Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused Pipelinemsn.com - December 18 at 8:45 AMFirst Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Companyfinance.yahoo.com - December 18 at 8:45 AMmarketbeat.com - December 18 at 6:05 AMFirst Wave BioPharma approves a 1-for-20 reverse stock splitmsn.com - December 14 at 3:35 PMFirst Wave BioPharma, Inc.: First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholdersfinanznachrichten.de - December 14 at 10:35 AMFirst Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholdersfinance.yahoo.com - December 14 at 10:35 AMFirst Wave BioPharma to Participate in BIO Partnering @JPM During “J.P. Morgan Week 2024”finance.yahoo.com - December 6 at 8:38 AM Get First Wave BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FWBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Could Your Accounts Be Frozen? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit FWBI Media Mentions By Week FWBI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FWBI News Sentiment▼0.000.42▲Average Medical News Sentiment FWBI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FWBI Articles This Week▼01▲FWBI Articles Average Week Get First Wave BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FWBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SONN News KZIA News SNPX News PXMD News ALZN News HOTH News CING News KTRA News OGEN News PTIX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FWBI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Wave BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
